Low STING expression promotes endometrial stromal cell invasion and migration via the STING/IRF-3/IFN-β1 pathway in eutopic endometrium of women with endometriosis

References

• Zondervan KT, Becker CM, Koga K, et al. Endometriosis. Nat Rev Dis Primers. 2018;4(1):9.
   PubMedGoogle Scholar
• Shigesi N, Kvaskoff M, Kirtley S, et al. The association between endometriosis and autoimmune diseases: a systematic review and meta-analysis. Hum Reprod Update. 2019;25(4):486–503.
   PubMed Web of Science ®Google Scholar
• Vallvé-Juanico J, Houshdaran S, Giudice LC. The endometrial immune environment of women with endometriosis. Hum Reprod Update. 2019;25(5):565–592.
   Web of Science ®Google Scholar
• Patel BG, Lenk EE, Lebovic DI, et al. Pathogenesis of endometriosis: interaction between endocrine and inflammatory pathways. Best Pract Res Clin Obstet Gynaecol. 2018;50:50–60.
   PubMed Web of Science ®Google Scholar
• Yi KW, Cho GJ, Park K, et al. Endometriosis is associated with adverse pregnancy outcomes: a national population-based study. Reprod Sci. 2020;27(5):1175–1180.
   PubMedGoogle Scholar
• Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783–801.
   PubMed Web of Science ®Google Scholar
• Yao Z, Zhang Y, Yan J, et al. Deciphering biomarkers of endometriosis by proteomic analysis of eutopic endometrium in infertile patients. J Gynecol Obstet Hum Reprod. 2020;50(5):102043.
   Web of Science ®Google Scholar
• Kaponis A, Iwabe T, Taniguchi F, et al. The role of NF-kappaB in endometriosis. Front Biosci (Schol Ed). 2012;4(4):1213–1234.
   PubMedGoogle Scholar
• Defrère S, González-Ramos R, Lousse JC, et al. Insights into iron and nuclear factor-kappa B (NF-kappaB) involvement in chronic inflammatory processes in peritoneal endometriosis. Histol Histopathol. 2011;26(8):1083–1092.
   PubMed Web of Science ®Google Scholar
• Guo Q, Chen X, Chen J, et al. STING promotes senescence, apoptosis, and extracellular matrix degradation in osteoarthritis via the NF-κB signaling pathway. Cell Death Dis. 2021;12(1):13.
   PubMed Web of Science ®Google Scholar
• Yum S, Li M, Fang Y, et al. TBK1 recruitment to STING activates both IRF3 and NF-κB that mediate immune defense against tumors and viral infections. Proc Natl Acad Sci U S A. 2021;118(14):e2100225118.
   PubMed Web of Science ®Google Scholar
• Burdette DL, Monroe KM, Sotelo-Troha K, et al. STING is a direct innate immune sensor of cyclic di-GMP. Nature. 2011;478(7370):515–518.
   PubMed Web of Science ®Google Scholar
• Le Naour J, Zitvogel L, Galluzzi L, et al. Trial watch: STING agonists in cancer therapy. OncoImmunology. 2020;9(1):1777624.
   PubMed Web of Science ®Google Scholar
• Tlemsani C, Pongor L, Elloumi F, et al. SCLC-CellMiner: a resource for small cell lung cancer cell line genomics and pharmacology based on genomic signatures. Cell Rep. 2020;33(3):108296.
   PubMed Web of Science ®Google Scholar
• Xu N, Palmer DC, Robeson AC, et al. STING agonist promotes CAR T cell trafficking and persistence in breast cancer. J Exp Med. 2021;218(2):e20200844.
   Web of Science ®Google Scholar
• Zhang Y, Li M, Li L, et al. β-arrestin 2 as an activator of cGAS-STING signaling and target of viral immune evasion. Nat Commun. 2020;11(1).
   Web of Science ®Google Scholar
• Qu H, Li L, Wang T-L, et al. Epithelial cells in endometriosis and adenomyosis upregulate STING expression. Reprod Sci. 2020;27(6):1276–1284.
   PubMed Web of Science ®Google Scholar
• Mirabutalebi SH, Karami N, Montazeri F, et al. The relationship between the expression levels of miR-135a and HOXA10 gene in the eutopic and ectopic endometrium. Int J Reprod Biomed. 2018;16(8):501–506.
   PubMed Web of Science ®Google Scholar
• Xu Z, Zhang L, Yu Q, et al. The estrogen-regulated lncRNA H19/miR-216a-5p axis alters stromal cell invasion and migration via ACTA2 in endometriosis. Mol Hum Reprod. 2019;25(9):550–561.
   PubMed Web of Science ®Google Scholar
• Qu H, Li L, Wang TL, et al. Epithelial cells in endometriosis and adenomyosis upregulate STING expression. Reprod Sci. 2020;27(6):1276–1284.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhang S, Han J, et al. Activation of STING pathway contributed to Cisplatin-Induced cardiac dysfunction via promoting the activation of TNF-α-AP-1 signal pathway. Front Pharmacol. 2021;12:711238.
   PubMedGoogle Scholar
• Zhang X, Wu H, Liu C, et al. The function of feline stimulator of interferon gene (STING) is evolutionarily conserved. Vet Immunol Immunopathol. 2016;169:54–62.
   PubMed Web of Science ®Google Scholar
• Lessey BA. The pathologists are free to go, or are they? Fertil Steril. 2013;99(2):350–351.
   PubMed Web of Science ®Google Scholar
• Saraswat L, Ayansina DT, Cooper KG, et al. Pregnancy outcomes in women with endometriosis: a national record linkage study. BJOG. 2017;124(3):444–452.
   PubMedGoogle Scholar
• Houshdaran S, Nezhat CR, Vo KC, et al. Aberrant endometrial DNA methylome and associated gene expression in women with endometriosis. Biol Reprod. 2016;95(5):93.
   Web of Science ®Google Scholar
• Tamaresis JS, Irwin JC, Goldfien GA, et al. Molecular classification of endometriosis and disease stage using high-dimensional genomic data. Endocrinology. 2014;155(12):4986–4999.
   PubMed Web of Science ®Google Scholar
• Ahn SH, Khalaj K, Young SL, et al. Immune-inflammation gene signatures in endometriosis patients. Fertil Steril. 2016;106(6):1420–1431.
   PubMed Web of Science ®Google Scholar
• Aghajanova L, Velarde MC, Giudice LC. Altered gene expression profiling in endometrium: evidence for progesterone resistance. Semin Reprod Med. 2010;28(01):051–058.
   PubMedGoogle Scholar
• Bruner-Tran KL, Herington JL, Duleba AJ, et al. Medical management of endometriosis: emerging evidence linking inflammation to disease pathophysiology. Minerva Ginecol. 2013;65(2):199–213.
   PubMedGoogle Scholar
• Zachariah R, Schmid S, Radpour R, et al. Circulating cell-free DNA as a potential biomarker for minimal and mild endometriosis. Reprod Biomed Online. 2009;18(3):407–411.
   PubMed Web of Science ®Google Scholar
• Traver S, Assou S, Scalici E, et al. Cell-free nucleic acids as non-invasive biomarkers of gynecological cancers, ovarian, endometrial and obstetric disorders and fetal aneuploidy. Hum Reprod Update. 2014;20(6):905–923.
   PubMed Web of Science ®Google Scholar